Raphael Pharmaceutical Inc. (RAPH) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2020: -$43.0K2021: $128.0K2022: $106.0K2023: $107.0K2024: -$742.0K2025: -$1.43M-$1.43M
2020Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025-$1.43M-93.1%
2024-$742.0K-793.5%
2023$107.0K+0.9%
2022$106.0K-17.2%
2021$128.0K+397.7%
2020-$43.0K